Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Endocarditis III: Medical Management

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...

Endocarditis IV: Nursing Management

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...

Endocarditis I: Introduction

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Myocarditis IV: Nursing Management

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diagnostic and prognostic value of time to positivity in blood cultures. An opinion paper.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2024

Same author

[Recommendations for the prevention of healthcare-associated infections in nursing homes].

Farmaceuticos comunitarios·2024

Same author

Invasive group A Streptococcus infection (Streptococcus pyogenes): Current situation in Spain.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2024

Same author

Human intestinal microbiome: Role in health and disease.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2024

Same author

Vascular catheter-related infections: an endemic disease in healthcare institutions. An opinion paper of the Spanish Society of Cardiovascular Infections (SEICAV).

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2024

Same author

New materials and complications of prostheses in humans: situation in Spain.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2024

Search research articles

Related Experiment Video

Updated: Jul 16, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Linezolid therapy for infective endocarditis.

P Muñoz¹, M Rodríguez-Creixéms¹, M Moreno²

¹Department of Clinical Microbiology-Infectious Diseases, Madrid, Spain.

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases

|March 3, 2007

Summary

Linezolid shows promise for treating infective endocarditis, particularly with resistant strains, achieving a 79% success rate in a case series. Further randomized trials are needed to confirm its efficacy and safety.

More Related Videos

In Vivo Mouse Model of Spinal Implant Infection

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

Related Experiment Videos

Last Updated: Jul 16, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

In Vivo Mouse Model of Spinal Implant Infection

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

Area of Science:

Infectious Diseases
Pharmacology
Clinical Medicine

Background:

Linezolid is an oxazolidinone antibiotic not currently a first-line treatment for infective endocarditis.
Infective endocarditis often involves challenging, multidrug-resistant pathogens.

Purpose of the Study:

To evaluate the efficacy and safety of linezolid in patients with infective endocarditis.
To assess linezolid's role in managing refractory or resistant cases of endocarditis.

Main Methods:

Retrospective analysis of nine patients treated with linezolid for endocarditis.
Inclusion of 33 similar cases from existing medical literature.
Review of treatment duration, outcomes, adverse events, and follow-up.

Main Results:

A high success rate of 79% was observed in 42 cases treated with linezolid.
Linezolid was primarily used for refractory disease (60%) or intolerance to other antibiotics (28%).
Reversible adverse effects were reported in 10 cases, with a mean follow-up of 8.5 months.

Conclusions:

Linezolid demonstrates potential as an effective treatment option for infective endocarditis, especially in challenging cases.
Further investigation through randomized controlled trials is essential to establish definitive guidelines for linezolid use in endocarditis.